Clinical and Diagnostic Virology
Volume 3, Issue 2, February 1995, Pages 139-153
ReportCMV PCR monitoring in leucocytes of transplant patients
References (38)
- et al.
Polymerase chain reaction to evaluate antiviral therapy for cytomegalovirus disease
Lancet
(1991) - et al.
Early occurrence of human cytomegalovirus infection after bone marrow transplantation, as demonstrated by the polymerase chain reaction technique
Blood
(1991) - et al.
Rapid diagnosis of cytomegalovirus infection in immunocompromised patients by detection of early antigen foci
Lancet
(1984) - et al.
A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts
N. Engl. J. Med.
(1989) - Barkholt, L., Johansson, B., Veress, B., Andersson, J. and Ehrnst, A. Detection of cytomegalovirus (CMV) — DNA in liver...
- et al.
The long persistence of CMV DNA in the blood of renal transplant patients after recovery from CMV infection
Transplantation
(1993) Isolation of leucocytes from human blood
A two-phase system for removal of red cells with methylcellulose as erythrocyte-aggregating agent
Scand. J. Clin. and Lab. Invest.
(1968)Separation of leucocytes: improvement in cell purity by fine adjustments of gradient, medium density and osmolality
Scand. J. Immunol.
(1991)- et al.
Primer-mediated enzymatic amplification of cytomegalovirus (CMV) DNA
Application to the early diagnosis of CMV infection in marrow transplant recipients
J. Clin. Invest.
(1989) - et al.
Cytomegalovirus infection of renal allografts
Detection by polymerase chain reaction
Transplantation
(1992)
Detection of cytomegalovirus in urine from newborns by using polymerase chain reaction DNA amplification
J. Infect. Dis.
(1988)
Low predictive value of polymerase chain reaction for diagnosis of cytomegalovirus disease in liver transplant recipients
J. Clin. Microbiol.
(1992)
Treatment of invasive cytomegalovirus disease in solid organ transplant patients with ganciclovir
Transplantation
(1991)
Detection of CMV-matrix pp65 antigen in leucocytes by immunofluorescence as a marker of CMV disease
J. Med. Virol.
(1993)
HLA class II gene polymorphism: DNA typing, evolution and relationship to disease susceptibility
Ganciclovir
A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections
Drugs
(1990)
Monitoring of human cytomegalovirus and ganciclovir treatment in heart transplant recipients by determination of viraemia, antigenemia and DNAemia
J. Infect. Dis.
(1991)
Comparison of standard tube and shell vial cell culture techniques for the detection of cytomegalovirus in clinical specimens
J. Clin. Microbiol.
(1985)
Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation
New Engl. J. Med.
(1991)
Cited by (40)
Molecular-based strategies for assessment of CMV infection and disease in immunosuppressed transplant recipients
2001, Clinical Microbiology and InfectionCitation Excerpt :The pp65 antigenemia test was found to be the least sensitive method for assessment of CMV activation, although the assay gave a better positive predictive value for identification of CMV disease than whole blood and plasma qualitative PCR assays. Since the antigenemia test is dependent on the type and quality of cells available from a peripheral blood sample, results can be unreliable or difficult to interpret for severely neutropenic patients (particularly BMT recipients) [11]. In our study, detection of cell-free plasma CMV DNA did not always correlate well with the methods that utilized cell-based samples for assessment of viral activation.
Arbovirus, herpesvirus, and enterovirus associated with neurological syndromes in adult patients of a university hospital, 2017-2018
2021, Revista da Sociedade Brasileira de Medicina Tropical
Copyright © 1995 Published by Elsevier B.V.